Navigation Links
Ambit Announces Presentations At The 55th Annual Meeting Of The American Society Of Hematology (ASH)
Date:12/9/2013

SAN DIEGO, Dec. 9, 2013 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced four oral presentations given at the 55th Annual ASH Conference in New Orleans, with data highlighting the Company's lead drug candidate, quizartinib. 

Results of the Phase 2b Randomized, Open-Label, Study of Lower Doses of Quizartinib in Subjects with FLT3-ITD Positive Relapsed Acute Myeloid Leukemia (AML): The purpose of this study is to assess the efficacy and safety of lower doses of quizartinib in the treatment of patients 18-years or older with relapsed/refractory FLT3 ITD positive AML to further improve the benefit:risk assessment of quizartinib.

This preliminary analysis is based on data available through May 28, 2013 with a minimum of eight weeks of follow up since the last subject first visit.  A total of 76 patients were enrolled from May 21, 2012 to March 27, 2013.  Median age for all patients was 55 (19-77) and 92% were FLT3-ITD(+).  35 patients remained in follow-up at the time of the analysis, and are currently censored for overall survival.  The following key information was presented:

For dose of 30mg:

  • The CRc rate was 47 percent (5 percent CR+CRp, 42 percent CRi)
  • The rate of HSCT after quizartinib use was 32 percent
  • The median overall survival was 20.7 weeks, with 16/38 patients censored as they remained in follow-up at the time of the analysis
  • Of the 12 patients who were bridged to HSCT, the median overall survival was 31 weeks
  • Grade 2 or greater QT prolongation was 11%, with a 5% grade 3 rate and no grade 4 events
  • For dose of 60mg:

  • The
    '/>"/>

  • SOURCE Ambit Biosciences
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Ambit Announces Participation At Oppenheimer 24th Annual Healthcare Conference
    2. Ambit Biosciences Provides Regulatory Update Following FDA Meeting Regarding Quizartinib (AC220)
    3. Ambit Biosciences to Announce Third Quarter 2013 Financial and Operating Results and Conference Call
    4. Ambit Biosciences Corporation Announces Second Quarter 2013 Operational Results
    5. Ambit Biosciences to Announce Second Quarter 2013 Operational Results and Conference Call
    6. Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
    7. Lo studio pubblicato su European Radiology esalta ulteriormente lutilizzo della tomosintesi al seno di Hologic nellambito dello screening del cancro con utilizzo della doppia lettura
    8. Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
    9. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
    10. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
    11. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/28/2014)... , Aug. 28, 2014 ... research report is available in its ... in Asia-Pacific Markets to 2020 - ... Need in Newly Diagnosed and Recurrent ... Glioblastoma Multiforme ...
    (Date:8/28/2014)... MEETING, Pa. , Aug. 28, 2014 /PRNewswire-USNewswire/ ... community, patients, and media, both for the promise ... patient safety. The quick deployment of surgical robots ... technology are prompting facilities to evaluate their robotic ... the entire surgical team.    ECRI ...
    (Date:8/28/2014)... NEW YORK , Aug. 28, ... a new market research report is ... ADHD Therapeutics to 2020 - Broadened ... to Drive Market Growth despite Patent ... ADHD Therapeutics to ...
    Breaking Medicine Technology:Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 2Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 2ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 3ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 4ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 6ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 7ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 8
    ... and TARRYTOWN, N.Y., March 19, 2012   Siemens Healthcare Diagnostics ... for Clinical Pathology (ASCP) have awarded ... and graduate medical laboratory students for the 2011-2012 academic year. ... was established in 2003 to address the nation,s ...
    ... 2012 Avaxia Biologics, Inc., a privately-held biotech company ... therapeutics for the treatment of gastrointestinal diseases, is proud ... of funding from the National Institutes of Health for ... been awarded a Phase II Small Business Innovation Research ...
    Cached Medicine Technology:Siemens and ASCP Award Over 100 Scholarships to Medical Laboratory Students in 2012 2Siemens and ASCP Award Over 100 Scholarships to Medical Laboratory Students in 2012 3Avaxia Biologics Awarded $1.5 Million Phase II SBIR Grant from NIH to Develop Oral Antibody Therapeutic for Inflammatory Bowel Disease 2
    (Date:8/29/2014)... (PRWEB) August 29, 2014 TayganPoint Consulting ... that for the second time, Inc. Magazine has named ... in America. , Based on solid revenue growth of ... No. 2341 overall on the list. TayganPoint’s repeat ... environment of the past few years, is a demonstration ...
    (Date:8/29/2014)... Pittsburgh, PA (PRWEB) August 29, 2014 "I ... four neck surgeries, as well as many other surgeries in ... inventor from Richmond, Texas. "During my stays, I was unable ... and many other ailments. Two nurses freely had to physically ... stood on either side of me and pulled the sheets. ...
    (Date:8/29/2014)... Innovations Television, produced by DMG Productions, announced today ... focusing on health and elderly care, slated to air first ... Americans over 65 will nearly double by 2030, expanding from ... for a total of 72 million people. Though many older ... least one chronic condition and use healthcare services more often ...
    (Date:8/29/2014)... 29, 2014 Many Americans are diagnosed ... diabetes type 2 at bay, patients should consider this ... the necessary lifestyle changes. While some diabetes risk factors ... advanced age, or belonging to certain ethnic groups, there ... their weight. Carrying extra pounds, especially in the abdomen, ...
    (Date:8/29/2014)... 2014 Fat is fat, right? Not necessarily. ... fat is usually stored in the upper chest and at ... itself in overflowing bellies, muffin tops, love handles and thunder ... many foods and promote better health, trans fats and saturated ... cholesterol levels and lower good cholesterol levels, increasing the risk ...
    Breaking Medicine News(10 mins):Health News:InventHelp® Client Develops Equipment for Surgical and Bedridden Patients (HCD-279) 2Health News:Innovations with Ed Begley, Jr., Seeking Content for Upcoming Series on Health and Elder Care 2Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 2Health News:Diet Doc Announces Specialized Diet Plans that Help Patients Prevent Diabetes by Stabilizing Blood Sugar Levels and Losing Excess Fat 3Health News:Diet Doc Announces Modernized, Interesting and Easy to Follow Diet Plans that Deliver Fast Weight Loss and Teach Patients the Difference Between Good and Bad Fat 2Health News:Diet Doc Announces Modernized, Interesting and Easy to Follow Diet Plans that Deliver Fast Weight Loss and Teach Patients the Difference Between Good and Bad Fat 3
    ... Research Center have cleared a major technical hurdle to making ... other blood cancers. In a study published in the ... and colleagues describe the first use of a method to ... of cord blood in the laboratory that were then infused ...
    ... , SUNDAY, Jan. 17 (HealthDay News) -- Giving a ... a stronger immune response than injected vaccines, say U.S. ... less vaccine to prompt an immune response. , Scarification ... the first smallpox vaccinations. Nearly all modern vaccines are ...
    ... ... patients by advocating for physician patient relationships which ensure optimal patient care and well ... of guidelines such as breast cancer screening that can negatively impact patients. , ... (PRWEB) January 17, 2010 ...
    ... - More relief goods, staff arrive, but challenges remain , ... - Agency reports "race against clock" to save lives in Haiti ... 16 World Vision relief workers, in a race against ... began arriving in Haiti,s quake-ravaged capital city yesterday.  Meanwhile, World Vision staff ...
    ... , WASHINGTON , ... International Development (USAID) Bureau for Global Health is sending additional ... rising medical needs.  Reports indicate that thousands of individuals in ... following Tuesday,s earthquake. , (Logo:   http://www.newscom.com/cgi-bin/prnh/20091022/USAIDLOGO ) , ...
    ... ... their new online store, featuring free shipping and the guaranteed lowest price on fitness equipment. ... Phoenix, AZ (PRWEB) January ... to announce the launch of their new online store, featuring free shipping and the guaranteed ...
    Cached Medicine News:Health News:First successful use of expanded umbilical-cord blood units to treat leukemia 2Health News:First successful use of expanded umbilical-cord blood units to treat leukemia 3Health News:Immune Response Better With Skin Scratch Vaccination 2Health News:Southern Medical Association Takes Position on Breast Cancer Screening 2Health News:Southern Medical Association Takes Position on Breast Cancer Screening 3Health News:Southern Medical Association Takes Position on Breast Cancer Screening 4Health News:HAITI QUAKE: World Vision Situation Update 2Health News:HAITI QUAKE: World Vision Situation Update 3Health News:HAITI QUAKE: World Vision Situation Update 4Health News:USAID's Global Health Bureau Responds to Haiti's Medical Crisis 2Health News:USAID's Global Health Bureau Responds to Haiti's Medical Crisis 3Health News:Fitness4HomeOnline.com Features Fitness Equipment Online with Free Shipping and Guaranteed Lowest Price 2
    DP 2020 Series 3-chip cameras offer the user unparalleled clarity and definition. Chroma dynamic range is extended and red colour reproduction is superb....
    ... Full frontal protection, our ... the shoulders by sturdy 2 ... with quick-acting snap hook fasteners. ... to custom fit the apron. ...
    ... added an elastic belt to help lift the ... Procedure Apron features all around protection to cover ... makes wearing and removing a breeze. ,For additional ... Belts - they reduce pressure on the vertebrae ...
    ... adjustable belt buckle. You adjust once and thats ... your shoulders. And now theres our Lady Style ... ,For additional back support try one of our ... the vertebrae and help lift the apron off ...
    Medicine Products: